59 related articles for article (PubMed ID: 10608261)
1. Peroxisome proliferators as adjuvants for the reverse-electron-transport therapy of obesity: an explanation for the large increase in metabolic rate of MEDICA 16-treated rats.
McCarty MF
Med Hypotheses; 1999 Oct; 53(4):272-6. PubMed ID: 10608261
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate and hydroxycitrate/carnitine may synergize to promote reverse electron transport in hepatocyte mitochondria, effectively 'uncoupling' the oxidation of fatty acids.
McCarty MF; Gustin JC
Med Hypotheses; 1999 May; 52(5):407-16. PubMed ID: 10416948
[TBL] [Abstract][Full Text] [Related]
3. Thermogenic and metabolic antiobesity drugs: rationale and opportunities.
Clapham JC; Arch JR
Diabetes Obes Metab; 2007 May; 9(3):259-75. PubMed ID: 17391151
[TBL] [Abstract][Full Text] [Related]
4. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
[TBL] [Abstract][Full Text] [Related]
5. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
6. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation.
Delaney J; Hodson MP; Thakkar H; Connor SC; Sweatman BC; Kenny SP; McGill PJ; Holder JC; Hutton KA; Haselden JN; Waterfield CJ
Arch Toxicol; 2005 Apr; 79(4):208-23. PubMed ID: 15838709
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway.
Waring JF; Yang Y; Healan-Greenberg CH; Adler AL; Dickinson R; McNally T; Wang X; Weitzberg M; Xu X; Lisowski A; Warder SE; Gu YG; Zinker BA; Blomme EA; Camp HS
J Pharmacol Exp Ther; 2008 Feb; 324(2):507-16. PubMed ID: 18025247
[TBL] [Abstract][Full Text] [Related]
10. Phenotype-based treatment of dietary obesity: differential effects of fenofibrate in obesity-prone and obesity-resistant rats.
Ji H; Outterbridge LV; Friedman MI
Metabolism; 2005 Apr; 54(4):421-9. PubMed ID: 15798946
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine.
McCarty MF
Med Hypotheses; 2001 Mar; 56(3):314-7. PubMed ID: 11359352
[TBL] [Abstract][Full Text] [Related]
12. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
13. Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator.
Scatena R; Bottoni P; Vincenzoni F; Messana I; Martorana GE; Nocca G; De Sole P; Maggiano N; Castagnola M; Giardina B
Chem Res Toxicol; 2003 Nov; 16(11):1440-7. PubMed ID: 14615970
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat liver acetyl-CoA carboxylase by beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).
Rose-Kahn G; Bar-Tana J
Biochim Biophys Acta; 1990 Feb; 1042(2):259-64. PubMed ID: 1967952
[TBL] [Abstract][Full Text] [Related]
15. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
17. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
18. Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis.
Kang SA; Hong K; Jang KH; Kim YY; Choue R; Lim Y
J Nutr Biochem; 2006 Jun; 17(6):419-26. PubMed ID: 16214330
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
